Accreditation: 6.75 AMA PRA Category 1 Credit™ | 6.75 ABIM MOC II | 6.75 ACPE Pharmacy | 6.75 Nursing Contact Hours
Venue: The Assembly, 5051 Centre Avenue, Pittsburgh, PA, United States
Official conference page for 2026 Pittsburgh Skin Cancer Conference. https://binaytara.org/projects/conferences/2026-pittsburgh-skin-cancer-conference
Saturday, April 11th, 2026
All timings are in Eastern Time (EDT, GMT-04:00) time.
Session Chair: John M Kirkwood, MD; Diwakar Davar, MD
09:30 AM - 10:00 AM
Case-based discussion #1: Role of surgical (SLN) and molecular (GEP) testing in the management of intermediate thickness melanoma – Sancy Leachman, MD, PhD
10:00 AM - 10:30 AM
Case Based discussion #2 : Adjuvant and neoadjuvant therapy in the management of high-risk resectable melanoma – John M Kirkwood, MD
Session Chair: Yana Najjar, MD
10:45 AM - 11:15 AM
Case-based discussion #1: Overview of 1st line options for metastatic cutaneous melanoma. – Tarek Haykal, MD
11:15 AM - 11:45 AM
Case-based discussion #2: 2nd line options including RP1, TIL and clinical trials – Yana Najjar, MD
Session Chair: Paul Harms, MD, PhD; Ankit Mangla, MD
12:45 PM - 01:05 PM
Case-based discussion #1: Molecular biology of MCC – Paul Harms, MD, PhD
01:05 PM - 01:25 PM
Case-based discussion #2: Adjuvant and neoadjuvant therapy for MCC (STAMP) – Kelly Lynn Harms, MD, PhD
01:25 PM - 01:45 PM
Case-based discussion #3: Management of advanced MCC – Ankit Mangla, MD
Session Chair: Kevin J Contrera, MD, MPH
01:45 PM - 02:05 PM
Case-based discussion #1: Neoadjuvant therapy for cSCC – Kevin J Contrera, MD, MPH
02:05 PM - 02:25 PM
Case-based discussion #2: Adjuvant therapy for cSCC (C-POST and KEYNOTE-630) – Shaum Sridharan, MD
02:25 PM - 02:45 PM
Case-based discussion #3: Management of advanced cSCC – Yusra Shao, MD
Session Chair: Kathryn Shahwan, MD
03:00 PM - 03:20 PM
Case-based discussion #1: Role of multidisciplinary team in the management of SOTR skin cancers – Kimberly Ken, MD
03:20 PM - 03:40 PM
Case-based discussion #2: Investigational immunotherapy for SOTR NMSC (CONTRAC-1, others) – Ami Greene, MD
03:40 PM - 04:00 PM
Case-based discussion #3: Novel treatments for the management of SOTR cSCC – Kathryn Shahwan, MD
04:00 PM - 04:20 PM
Case- Based Discussion #4 : Cutaneous SCC risk prognostication (riSCC, COMPASS, GEP) – David Carr, MD, MPH
Session Chair: Melissa Pugliano-Mauro, MD
04:20 PM - 04:40 PM
Case Based #1: Role of RT in the management of NMSC – Yvonne Mowery, MD, PhD
04:40 PM - 05:00 PM
Case Based #2: RLT and theranostics in melanoma and NMSC – Ravi Patel, MD, PhD
05:00 PM - 05:20 PM
Case Based # 3 : Coordination Of Care in high risk NMSC – Hannah Glass, PA-C
